|
|
Gene Symbol |
CD4 |
|
Aliases |
CD4mut |
|
Entrez Gene ID |
|
|
Gene Name |
CD4 molecule |
|
Chromosomal Location |
12p13.31 |
|
HGNC ID |
|
|
Summary |
This gene encodes a membrane glycoprotein of T lymphocytes that interacts with major histocompatibility complex class II antigenes and is also a receptor for the human immunodeficiency virus. This gene is expressed not only in T lymphocytes, but also in B cells, macrophages, and granulocytes. It is also expressed in specific regions of the brain. The protein functions to initiate or augment the early phase of T-cell activation, and may function as an important mediator of indirect neuronal damage in infectious and immune-mediated diseases of the central nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been identified in this gene. [provided by RefSeq, Aug 2010]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0001934 |
Biological process |
Positive regulation of protein phosphorylation |
IDA |
24942581 |
GO:0006948 |
Biological process |
Induction by virus of host cell-cell fusion |
IDA |
9166430 |
GO:0006955 |
Biological process |
Immune response |
NAS |
8512039 |
GO:0007165 |
Biological process |
Signal transduction |
TAS |
9558100, 10358157 |
GO:0007166 |
Biological process |
Cell surface receptor signaling pathway |
TAS |
9780207 |
GO:0007167 |
Biological process |
Enzyme linked receptor protein signaling pathway |
TAS |
10358157 |
GO:0007169 |
Biological process |
Transmembrane receptor protein tyrosine kinase signaling pathway |
NAS |
8512039 |
GO:0030217 |
Biological process |
T cell differentiation |
IDA |
1533274 |
GO:0030225 |
Biological process |
Macrophage differentiation |
IMP |
24942581 |
GO:0032507 |
Biological process |
Maintenance of protein location in cell |
IDA |
15128768 |
GO:0033674 |
Biological process |
Positive regulation of kinase activity |
IDA |
24942581 |
GO:0035723 |
Biological process |
Interleukin-15-mediated signaling pathway |
IBA |
21873635 |
GO:0035723 |
Biological process |
Interleukin-15-mediated signaling pathway |
IDA |
24942581 |
GO:0042110 |
Biological process |
T cell activation |
IBA |
21873635 |
GO:0043123 |
Biological process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
IDA |
24942581 |
GO:0043410 |
Biological process |
Positive regulation of MAPK cascade |
IDA |
24942581 |
GO:0045058 |
Biological process |
T cell selection |
IDA |
9551897 |
GO:0045086 |
Biological process |
Positive regulation of interleukin-2 biosynthetic process |
NAS |
1901411 |
GO:0045657 |
Biological process |
Positive regulation of monocyte differentiation |
IDA |
24942581 |
GO:0045860 |
Biological process |
Positive regulation of protein kinase activity |
IDA |
2118992 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IDA |
24942581 |
GO:0046598 |
Biological process |
Positive regulation of viral entry into host cell |
IDA |
24942581 |
GO:0050863 |
Biological process |
Regulation of T cell activation |
IDA |
1533274 |
GO:0051924 |
Biological process |
Regulation of calcium ion transport |
IDA |
24942581 |
GO:0070374 |
Biological process |
Positive regulation of ERK1 and ERK2 cascade |
IBA |
21873635 |
GO:0070374 |
Biological process |
Positive regulation of ERK1 and ERK2 cascade |
IDA |
24942581 |
GO:0097011 |
Biological process |
Cellular response to granulocyte macrophage colony-stimulating factor stimulus |
IDA |
24942581 |
GO:0005886 |
Cellular component |
Plasma membrane |
IDA |
2823150, 8124721, 11390434, 19333378 |
GO:0005887 |
Cellular component |
Integral component of plasma membrane |
IDA |
24942581 |
GO:0009897 |
Cellular component |
External side of plasma membrane |
IBA |
21873635 |
GO:0009897 |
Cellular component |
External side of plasma membrane |
IDA |
17213291 |
GO:0042101 |
Cellular component |
T cell receptor complex |
NAS |
8512039 |
GO:0045121 |
Cellular component |
Membrane raft |
IBA |
21873635 |
GO:0045121 |
Cellular component |
Membrane raft |
IDA |
9168119 |
GO:0004888 |
Molecular function |
Transmembrane signaling receptor activity |
TAS |
10358157 |
GO:0005201 |
Molecular function |
Extracellular matrix structural constituent |
NAS |
12444132 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
7831289, 9168119, 10816381, 10922058, 11113139, 11264384, 15660419, 16888650, 17005671, 17301785, 19333378, 20080564, 20357769, 23890821, 26098315 |
GO:0008270 |
Molecular function |
Zinc ion binding |
IDA |
9668045 |
GO:0015026 |
Molecular function |
Coreceptor activity |
NAS |
8512039 |
GO:0019899 |
Molecular function |
Enzyme binding |
IPI |
19333378 |
GO:0019901 |
Molecular function |
Protein kinase binding |
IPI |
7486703 |
GO:0038023 |
Molecular function |
Signaling receptor activity |
TAS |
10413516 |
GO:0042011 |
Molecular function |
Interleukin-16 binding |
IPI |
24942581 |
GO:0042012 |
Molecular function |
Interleukin-16 receptor activity |
IDA |
24942581 |
GO:0042289 |
Molecular function |
MHC class II protein binding |
IBA |
21873635 |
GO:0042289 |
Molecular function |
MHC class II protein binding |
IDA |
2823150, 11535811 |
GO:0042289 |
Molecular function |
MHC class II protein binding |
IPI |
24942581 |
GO:0042289 |
Molecular function |
MHC class II protein binding |
NAS |
8512039 |
GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
9168119 |
GO:0042803 |
Molecular function |
Protein homodimerization activity |
IDA |
9168119, 12444132 |
GO:1990782 |
Molecular function |
Protein tyrosine kinase binding |
IBA |
21873635 |
GO:1990782 |
Molecular function |
Protein tyrosine kinase binding |
IPI |
3262426 |
|
Protein Information |
|
Protein Name |
T-cell surface glycoprotein CD4, CD4 antigen (p55), CD4 receptor, T-cell surface antigen T4/Leu-3 |
|
Function |
Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. In T-cells, functions primarily as a coreceptor for MHC class II molecule:peptide complex. The antigens presented by class II peptides are derived from extracellular proteins while class I peptides are derived from cytosolic proteins. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class II presented by antigen presenting cells (APCs). In turn, recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. LCK then initiates different intracellular signaling pathways by phosphorylating various substrates ultimately leading to lymphokine production, motility, adhesion and activation of T-helper cells. In other cells such as macrophages or NK cells, plays a role in differentiation/activation, cytokine expression and cell migration in a TCR/LCK-independent pathway. Participates in the development of T-helper cells in the thymus and triggers the differentiation of monocytes into functional mature macrophages. .; (Microbial infection) Primary receptor for human immunodeficiency virus-1 (HIV-1) (PubMed:2214026, PubMed:16331979, PubMed:9641677, PubMed:12089508). Down-regulated by HIV-1 Vpu (PubMed:17346169). Acts as a receptor for Human Herpes virus 7/HHV-7 (PubMed:7909607). |
|
|
|
|
|
UniProt |
|
|
PDB |
3S4S, 3S5L, 3T0E, 2JKR, 2JKT, 1OPN, 1OPT, 1OPW, 6MEO, 6MET, 1CDH, 1CDI, 1CDJ, 1CDU, 1CDY, 1G9M, 1G9N, 1GC1, 1JL4, 1Q68, 1RZJ, 1RZK, 1WBR, 1WIO, 1WIP, 1WIQ, 2B4C, 2KLU, 2NXY, 2NXZ, 2NY0, 2NY1, 2NY2, 2NY3, 2NY4, 2NY5, 2NY6, 2QAD, 3B71, 3CD4, 3J70, 3JCB, 3JCC, 3JWD, 3JWO, 3LQA, 3O2D, 4H8W, 4JM2, 4P9H, 4Q6I, |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000263341 |
|
P01584 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
PCOS |
|
Immune System Diseases |
T4 Epitope Defiency |
|
AIDS |
|
Neoplasms |
Vulvar Cancer |
|
Nervous System Diseases |
Muscular Dystrophy |
|
Psychiatric/Brain disorders |
Obstructive Sleep Apnea |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
CD3, CD4, CD14, CD15, CD45, CD45RA, CD45RO, CD57,CSF-1,(MHC) class II,(GM)-CSF,IL-1beta, IL-6, IL-8 and IL-10,MCP-1,TNFalpha |
|
|
NIH criteria |
Related
|
|
CD45RO+ cells (activated/memory T lymphocytes) were reduced by 60% in the theca layer of follicles from PCOS women. |
|
CD28 |
Cardiovascular disease,type 2 diabetes mellitus,coronary instability |
|
Rotterdam criteria |
Related
|
|
The study demonstrates that women with PCOS showed an expansion of CD4(+)CD28(null) T cells, an aggressive population of T lymphocytes that has been recently associated with recurrent coronary instability and type 2 diabetes mellitus. |
|
CD28 |
Cardiovascular risk,type 2 diabetes mellitus,coronary instability |
|
Rotterdam criteria |
Related
|
|
Cardiovascular risk evaluation should be performed in all PCOS phenotypes. In particular, we demonstrated that the non-H phenotype has potentially increased cardiovascular risk in terms of CD4(+)CD28(null) frequency. |
|
|
|
|